Form 8 (OPD) - Nestor Healthcare
16 Agosto 2010 - 5:02AM
UK Regulatory
TIDMNSR
RNS Number : 1226R
Nestor Healthcare Group PLC
16 August 2010
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
+-----------------+------------+
| (a) | Nestor |
| Identity | Healthcare |
| of the | Group plc |
| party to | |
| the | |
| offer | |
| making | |
| the | |
| disclosure: | |
+-----------------+------------+
| (b) | N/A |
| Owner | |
| or | |
| controller | |
| of | |
| interests | |
| and short | |
| positions | |
| disclosed, | |
| if | |
| different | |
| from 1(a): | |
| The | |
| naming of | |
| nominee or | |
| vehicle | |
| companies | |
| is | |
| insufficient | |
+-----------------+------------+
| (c) | Nestor |
| Name | Healthcare |
| of | Group plc |
| offeror/offeree | |
| in relation to | |
| whose relevant | |
| securities this | |
| form relates: | |
| Use a | |
| separate form | |
| for each party | |
| to the offer | |
+-----------------+------------+
| (d) Is | OFFEREE |
| the | |
| party | |
| to the | |
| offer | |
| making | |
| the | |
| disclosure | |
| the | |
| offeror or | |
| the | |
| offeree? | |
+-----------------+------------+
| (e) | 11 |
| Date | August |
| position | 2010 |
| held: | |
+-----------------+------------+
| (f) | NO |
| Has | |
| the | |
| party | |
| previously | |
| disclosed, | |
| or is it | |
| today | |
| disclosing, | |
| under the | |
| Code in | |
| respect of | |
| any other | |
| party to | |
| this offer? | |
+-----------------+------------+
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the
offeror or offeree to which the disclosure relates
+----------------+--------+--------+--------+--------+
| Class | |
| of | |
| relevant | |
| security: | |
| | |
+----------------+-----------------------------------+
| | Interests |Short positions |
| | | |
+ +-----------------+-----------------+
| |Number | % |Number | % |
+----------------+--------+--------+--------+--------+
| (1) | Nil | | Nil | |
| Relevant | | | | |
| securities | | | | |
| owned | | | | |
| and/or | | | | |
| controlled: | | | | |
+----------------+--------+--------+--------+--------+
| (2) | Nil | | Nil | |
| Derivatives | | | | |
| (other than | | | | |
| options): | | | | |
+----------------+--------+--------+--------+--------+
| (3) | Nil | | Nil | |
| Options | | | | |
| and | | | | |
| agreements | | | | |
| to | | | | |
| purchase/sell: | | | | |
+----------------+--------+--------+--------+--------+
| | Nil | | Nil | |
| | | | | |
| TOTAL: | | | | |
+----------------+--------+--------+--------+--------+
All interests and all short positions should be disclosed.
Details of any open derivative or option positions, or agreements to purchase or
sell relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
+--------------+--------+
| Class | Nil |
| of | |
| relevant | |
| security | |
| in | |
| relation | |
| to which | |
| subscription | |
| right | |
| exists: | |
+--------------+--------+
| Details, | Nil |
| including | |
| nature of | |
| the | |
| rights | |
| concerned | |
| and | |
| relevant | |
| percentages: | |
+--------------+--------+
If there are positions or rights to subscribe to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2(a)
or (b) (as appropriate) for each additional class of relevant security.
(c) Irrevocable commitments and letters of intent
+-------------+
| Details |
| of any |
| irrevocable |
| commitments |
| or letters |
| of intent |
| procured by |
| the party |
| to the |
| offer |
| making the |
| disclosure |
| or any |
| person |
| acting in |
| concert |
| with it |
| (see Note 3 |
| on Rule |
| 2.11 of the |
| Code): |
+-------------+
| |
| None |
| |
+-------------+
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER
MAKING THE DISCLOSURE
+---------+----------+----------+---------+----+------------+----------+
| Details of any interests, short positions and rights to subscribe |
| of any person acting in concert with the party to the offer making |
| the disclosure: |
+----------------------------------------------------------------------+
| |
| Schroder Investment Management is interested in 32,784,018 shares |
| in Nestor Healthcare Group plc (the "Company") representing 29.05% |
| of the issued share capital of the Company. |
| |
| Gartmore Investment Management is interested in 32,831,516 shares |
| in the Company representing 29.09% of the issued share capital of |
| the Company. |
| |
+----------------------------------------------------------------------+
| |
| The directors of the Company have the following beneficial |
| interests in the Company: |
| |
+----------------------------------------------------------------------+
| Director: | No. of shares held |
| | % of issued share capital |
| | |
+-----------------------------------------+----------------------------+
| Roger Dye | 150,000 |
+-----------------------------------------+----------------------------+
| | 0.133% |
+-----------------------------------------+----------------------------+
| | |
+-----------------------------------------+----------------------------+
| Martyn Ellis | 47,292 |
+-----------------------------------------+----------------------------+
| | 0.042% |
+-----------------------------------------+----------------------------+
| | |
+-----------------------------------------+----------------------------+
| Sir Andrew Foster | 87,957 |
+-----------------------------------------+----------------------------+
| | 0.078% |
+-----------------------------------------+----------------------------+
| | |
+-----------------------------------------+----------------------------+
| John Rennocks | 437,794 |
+-----------------------------------------+----------------------------+
| | 0.388% |
+-----------------------------------------+----------------------------+
| | |
+-----------------------------------------+----------------------------+
| The following directors of the Company have the following |
| beneficial interests in shares in the Company pursuant to options |
| or similar arrangements: |
| |
+----------------------------------------------------------------------+
| Martyn Ellis |
| |
+----------------------------------------------------------------------+
| Details | Class | No. of | Option | Relevant | Exercise |
| | | Shares | Scheme | Date | Price |
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 193,187 | Share Option | Expiry | 25.67p |
| Options | | | Plan 2002 | Date: | |
| | | | | 22/04/2019 | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 104,756 | Share Option | Expiry | 54.50p |
| Options | | | Plan 2002 | Date: | |
| | | | | 22/04/2020 | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 20,814 | SAYE Scheme | Exercise | 43.60p |
| Options | | | | Date: | |
| | | | | 30/06/2013 | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 292,788 | Performance | Vesting | N/A |
| Awards | | | Share Plan | Date: | |
| | | | 2006 | 21/05/2011 | |
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 420,371 | Performance | Vesting | N/A |
| Awards | | | Share Plan | Date: | |
| | | | 2006 | 22/04/2012 | |
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 191,116 | Performance | Vesting | N/A |
| Awards | | | Share Plan | Date: | |
| | | | 2006 | 22/04/2013 | |
+---------+----------+----------+--------------+------------+----------+
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| John Ivers |
| |
+----------------------------------------------------------------------+
| Details | Class | No. of | Option | Relevant | Exercise |
| | | Shares | Scheme | Date | Price |
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 151,790 | Share Option | Expiry | 25.67p |
| Options | | | Plan 2002 | Date: | |
| | | | | 22/04/2019 | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 97,447 | Share Option | Expiry | 54.50p |
| Options | | | Plan 2002 | Date: | |
| | | | | 22/04/2020 | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 46,399 | SAYE Scheme | Exercise | 19.72p |
| Options | | | | Date: | |
| | | | | 30/06/2013 | |
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 216,346 | Performance | Vesting | N/A |
| Awards | | | Share Plan | Date: | |
| | | | 2006 | 21/05/2011 | |
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 330,291 | Performance | Vesting | N/A |
| Awards | | | Share Plan | Date: | |
| | | | 2006 | 22/04/2012 | |
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 177,782 | Performance | Vesting | N/A |
| Awards | | | Share Plan | Date: | |
| | | | 2006 | 22/04/2013 | |
+---------+----------+----------+--------------+------------+----------+
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| John Rennocks |
| |
+----------------------------------------------------------------------+
| Details | Class | No. of | Option | Relevant | Exercise |
| | | Shares | Scheme | Date | Price |
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 79,361 | SAYE Scheme | Exercise | 19.72p |
| Options | | | | Date: | |
| | | | | 30/06/2015 | |
+---------+----------+----------+--------------+------------+----------+
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| Roger Dye |
| |
+----------------------------------------------------------------------+
| Details | Class | No. of | Option | Relevant | Exercise |
| | | Shares | Scheme | Date | Price |
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| Share | Ordinary | 35,665 | SAYE Scheme | Exercise | 43.60p |
| Options | | | | Date: | |
| | | | | 30/06/2015 | |
+---------+----------+----------+--------------+------------+----------+
| | | | | | |
+---------+----------+----------+--------------+------------+----------+
| | | | | | | |
+---------+----------+----------+---------+----+------------+----------+
If there are positions or rights to subscribe to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 3 for
each additional class of relevant security.
Details of any open derivative or option positions, or agreements to purchase or
sell relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
+-----------------+
| Details |
| of any |
| indemnity |
| or option |
| arrangement, |
| or any |
| agreement or |
| understanding, |
| formal or |
| informal, |
| relating to |
| relevant |
| securities |
| which may be |
| an inducement |
| to deal or |
| refrain from |
| dealing |
| entered into |
| by the party |
| to the offer |
| making the |
| disclosure or |
| any person |
| acting in |
| concert with |
| it: |
| If there are |
| no such |
| agreements, |
| arrangements |
| or |
| understandings, |
| state "none" |
+-----------------+
| |
| None |
| |
+-----------------+
(b) Agreements, arrangements or understandings relating to options or
derivatives
+-----------------+
| Details |
| of any |
| agreement, |
| arrangement |
| or |
| understanding, |
| formal or |
| informal, |
| between the |
| party to the |
| offer making |
| the |
| disclosure, or |
| any person |
| acting in |
| concert with |
| it, and any |
| other person |
| relating to: |
| (i) the |
| voting rights |
| of any |
| relevant |
| securities |
| under any |
| option; or |
| (ii) the |
| voting rights |
| or future |
| acquisition or |
| disposal of |
| any relevant |
| securities to |
| which any |
| derivative is |
| referenced: |
| If there are |
| no such |
| agreements, |
| arrangements |
| or |
| understandings, |
| state "none" |
+-----------------+
| |
| None |
| |
+-----------------+
(c) Attachments
Are any Supplemental Forms attached?
+--------------+--------+
| Supplemental | NO |
| Form 8 (Open | |
| Positions) | |
+--------------+--------+
| Supplemental | NO |
| Form 8 (SBL) | |
+--------------+--------+
+-------------+--------------+
| Date | 16 |
| of | August |
| disclosure: | 2010 |
+-------------+--------------+
| Contact | David |
| name: | Collison |
+-------------+--------------+
| Telephone | 01707 255631 |
| number: | |
+-------------+--------------+
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service and must also be emailed to the Takeover Panel at
monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available
for consultation in relation to the Code's dealing disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FEEEAEPKFEEEEFF
Nestor Healthcare (LSE:NSR)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Nestor Healthcare (LSE:NSR)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
Real-Time news about Nestor Health. (London Stock Exchange): 0 recent articles
Más de Nestor Health. Artículos de Noticias